Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Pharmorubicin 50mg/25ml solution for injection Cytosafe vials (Pfizer Ltd) |
| BNF code | 0801020N0BBAEAE |
| Virtual Medicinal Product | Epirubicin 50mg/25ml solution for injection vials |
| Name | Pharmorubicin 50mg/25ml solution for injection Cytosafe vials |
| Abbreviated name | Pharmorubicin 50mg/25ml inj Cytosafe vials |
| Date of name applicability | 26 Feb 2014 |
| Previous name | Pharmorubicin 50mg/25ml solution for injection vials |
| Supplier | Pfizer Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Licensed Route | |
| Licenced route | Intravesical |
| Actual Medicinal Product Packs | |
| Pharmorubicin 50mg/25ml solution for injection Cytosafe vials (Pfizer Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.